A chewable pediatric fixed-dose combination tablet of stavudine, lamivudine, and nevirapine: Pharmacokinetics and safety compared with the individual liquid formulations in human immunodeficiency virus-infected children in Thailand

Background: Pediatric fixed-dose combinations (FDCs) are needed to facilitate antiretroviral therapy in children. We evaluated the relative bioavailability, safety, and therapeutic adequacy of a novel chewable pediatric FDC tablet of stavudine (7 mg), lamivudine (30 mg), and nevirapine (50 mg), refe...

Full description

Saved in:
Bibliographic Details
Main Authors: Vanprapar N., Cressey T.R., Chokephaibulkit K., Muresan P., Plipat N., Sirisanthana V., Prasitsuebsai W., Hongsiriwan S., Chotpitayasunondh T., Eksaengsri A., Toye M., Smith M.E., McIntosh K., Capparelli E., Yogev R.
Format: Article
Language:English
Published: 2014
Online Access:http://www.scopus.com/inward/record.url?eid=2-s2.0-77957278518&partnerID=40&md5=922bd14f213bb00e000de73c38274a27
http://cmuir.cmu.ac.th/handle/6653943832/855
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Chiang Mai University
Language: English

Similar Items